11
November

08:00 AM PST

Clinical Operations

Name: Clinical Operations & Clinical Trial Supply Chain Strategy Meeting West Coast 2025
Start: 2025-11-11T08:00
End: 2025-11-11T18:00
Location: Hard Rock Hotel San Diego

&

Clinical Trial Supply Chain

Strategy Meeting West Coast USA 2025

Jumpstart Clinical Operations on Patient Centricity, Innovation and Efficiency

Hard Rock Hotel San Diego

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Clinical Operations Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered.

Proventa International’s Clinical Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Clinical Operations professionals from across the West Coast in San Diego, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the West Coast, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Meet Our Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at Clinical Operations Strategy Meetings.

Anthony Maida

Chief Clinical Officer – Translational Medicine Oncotelic Therapeutics, Inc.

Dr. Maida is currently Chief Clinical Officer – Translational Medicine for Oncotelic, Inc. focused on the immunotherapy of cancer and infectious disease.  Formerly he was Senior Vice President – Clinical Research for Northwest Biotherapeutics, Inc., a cancer vaccine company focused on therapy of patients with glioblastoma multiforme and prostate cancer.  He is responsible for the oversight of the clinical and scientific operations of Oncotelic Therapeutics, Inc.  Dr. Maida was formerly Vice President of Clinical Research and General Manager, Oncology, World-wide for PharmaNet, Inc.  Prior to coming to Pharmanet Dr. Maida served as Chairman, Founder and Director of BioConsul Drug Development Corporation and Principal of Anthony Maida Consulting International, servicing pharmaceutical firms, venture capital, hedge funds and Wall Street, in the clinical development of therapeutic products and product/company acquisitions. For 30 years, Dr. Maida has focused on the clinical development of immunotherapies to treat patients with cancer.  Dr. Maida’s skill set includes the execution and oversight of finance, operations, research, and commercial clinical and scientific development, regulatory and manufacturing for the development of various therapeutic modalities.  Dr. Maida has served in a number of executive roles, including, Chairman, CEO, COO, CSO, CFO and business development.  Dr. Maida serves or has served on the advisory board of EndPoint BioCapital, Sdn Bhd (Kuala Lumpur, Malaysia), and as an advisor, consultant and technical analyst for CMX Capital, LLC, Sagamore Bioventures, Roaring Fork Capital, Toucan Capital, North Sound Capital, The Bonnie J. Addario Lung Cancer Foundation and Pediatric BioScience, Inc.  Additionally, Dr. Maida has been retained by Abraxis BioScience, Inc., Northwest BioTherapeutics, Inc. and Takeda Chemical Industries, Ltd. (Osaka, Japan). Dr. Maida sat on multiple public company boards and advisory committees.  Dr. Maida holds a B.A. degree in Biology, a B.A. Degree in History, a MBA, a MA in toxicology and a Ph.D. in Immunology.  He is a member of the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR), the Society of Neuro-Oncology (SNO), the International Society for Biological Therapy of Cancer (iSBTc) and the American Chemical Society.  Dr. Maida holds a number of patents and patent applications associated with various therapeutic modalities and approaches.

Christie Quarles

Clinical Analytics Product Marketing Manager Revvity Signals

David Crean

Managing Partner & Partner Cardiff Advisory LLC & 1004 Venture Partners

Elie Arslan

Head, Quality, Principal Investigator and Program Management Cellics Therapeutics, Inc.

George Ng

Chief Executive Officer Processa Pharmaceuticals

George Ng is a seasoned executive and entrepreneur in the life sciences industry, currently serving as Chief Executive Officer and Board Director at Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) and as a partner at PENG Life Science Ventures (PENG LSV). Previously, he was President, COO, and Board Director at Calidi Biotherapeutics, Inc. (NYSE: CLDI), where he led the company’s successful public listing.
Mr. Ng co-founded Scilex Pharmaceuticals, Inc. (NASDAQ: SCLX), guiding it through product development, clinical trials, FDA approval, $140 million in financing, and its commercial launch and sale. His leadership career also includes senior executive roles at Sorrento Therapeutics, BioDelivery Sciences, Spectrum Pharmaceuticals, and Alpharma (now part of Pfizer), contributing to multiple successful drug product launches.
Before entering industry, Mr. Ng was a partner at two Am Law 200 firms, where he founded and led a national life sciences practice. He has served on the boards of several biotech companies and is a frequent speaker on legal, regulatory, and business topics.
Mr. Ng holds a Juris Doctor from the University of Notre Dame School of Law and a B.A.S. in Biochemistry and Economics from the University of California, Davis.

Glenn Guthrie

Senior Principal Clinical Solutions Strategy Revvity Signals

Jacqui Blem

Vice President, Clinical Operations Wugen

Janal Urich

Vice President, Clinical Operations Atara Biotherapeutics

John Mattison

Former Operating Partner, Chief Medical Information Officer Arsenal Capital Partners

Joseph Shan

Vice President, Clinical Operations Adcentrx Therapeutics

Peter Stiegler

Vice President, Clinical Operations Oncology HUYA Bioscience International

Sandy Wiley

Former Senior Director Nonclinical & Translational Sciences (Department Head) MEI Pharma

Shaun MacEachern

Executive Director, Clinical Supply Chain Kumquat Biosciences Inc.

Tara Lehner

Vice President, Clinical Operations INmune Bio Inc.

Our Agenda

See Which Topics Are Up For Discussion

09:00 – 10:00

Roundtable Tracks

Emerging Biopharma / Outsourcing / Patient Recruitment
Working Under Cost Constraints While Building and Flexing a Scalable Team (i.e., doing more with less)

-Tara Lehner
Vice President, Clinical Operations
INmune Bio Inc.

Clinical Technologies / Artificial Intelligence / Decentralized & Hybrid Trials
Utilizing AI to Accelerate Clinical Trials and Drug Development

-Sandy Wiley
Former Senior Director Nonclinical & Translational Sciences (Department Head)
MEI Pharma

Early Phase, Global Site Selection & Feasibility Study
How Emerging Technologies are Transforming Feasibility Assessments andSite Selection Decisions

-Gregory Opiteck
Vice President Head of Translational Sciences
Allogene Therapeutics

Clinical Supplies, Global Networks, Storage & Distribution
Overcoming Global Logistics Challenges in Clinical Trial Supply Chains Across Borders

Private Equity & Venture Capital
Navigating Financial Risks and Rewards in Biotech: Investment Trends in 2025 and Strategies for 2026

-David Crean
Managing Partner & Partner
Cardiff Advisory LLC & 1004 Venture Partners

11:10 – 12:10

Roundtable Tracks

Emerging Biopharma / Outsourcing / Patient Recruitment
Enhancing Patient Engagement in Clinical Trials: The What and How of Patient Centricity

-Elie Arslan
Head, Quality, Principal Investigator and Program Management
Cellics Therapeutics, Inc.

Clinical Technologies / Artificial Intelligence / Decentralized & Hybrid Trials
Ensuring Ethical Integrity in the Use of Advanced Technologies in Responsible Clinical Trials

-Madhu Mukundan
Associate Director, Clinical Operations
AnaptysBio Inc.

Early Phase, Global Site Selection & Feasibility Study
Optimizing Biomarker Discovery and Validation in Early Phase Clinical Trials

-Anthony Maida
Chief Clinical Officer – Translational Medicine
Oncotelic Therapeutics, Inc.

Clinical Supplies, Global Networks, Storage & Distribution
Ensuring Cold Chain Integrity: Navigating Temperature-Controlled Logistics in Global Clinical Trials

Private Equity & Venture Capital
Crossroads Between Life Sciences and Cryptocurrency in Investing

-George Ng
Chief Executive Officer
Processa Pharmaceuticals

12:10 – 12:55

13:35 – 14:05

Revvity Signals – From Oversight to Insight: Accelerating Clinical Operations with AI-Augmented Data Review

PRESENTER: Glenn Guthrie, Senior Principal Clinical Solutions Strategy, Revvity Signals PRESENTER: Christie Quarles, Clinical Product Marketing Manager, Revvity Signals

14:05 – 15:05

Roundtable Tracks

Emerging Biopharma / Outsourcing / Patient Recruitment
The IPO Slump: Implications for the Future of Emerging Biopharma

-Joseph Shan
Vice President, Clinical Operations
Adcentrx Therapeutics

Clinical Technologies / Artificial Intelligence / Decentralized & Hybrid Trials
Leveraging Technology for Streamlined Trial Execution

-Olu Adegoke
Head, Clinical Data Management-ATRI
Keck School of Medicine of the University of Southern California (ATRI)

Early Phase, Global Site Selection & Feasibility Study
Collaborative Approaches to Streamline Global Site Selection and Feasibility Assessments

-Jacqui Blem
Vice President, Clinical Operations
Wugen

Clinical Supplies, Global Networks, Storage & Distribution
Optimizing Clinical Trial Supply Chains: Effective Strategies for Streamlined Pharmaceutical Research

-Barbara Blouw
Senior Director, Clinical Operations
Y-mAbs Therapeutics, Inc.

Private Equity & Venture Capital
Exploring the Key Strategies for Improving the Cost-Efficiency of Clinical Trials and Increasing ROI for Investors?

-John Mattison
Former Operating Partner, Chief Medical Information Officer
Arsenal Capital Partners

Press play to hear what your colleagues had to say…

Hotel & Venue

Hard Rock Hotel San Diego

You’re the main act in San Diego. At Hard Rock Hotel, we immerse you in our musical amenities, world-class service, and intoxicating location in downtown San Diego. Tour the Gaslamp Quarter on an Electra bike and walk a block to Petco Park.

Hotel Details Map & Directions Parking

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Here To Help

Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

Clinical Trials San Diego

Clinical Operations & Clinical Trial Supply Chain Strategy Meeting West Coast 2024

&

Strategy Meeting West Coast USA 2025

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Hard Rock Hotel San Diego

Fresh Clinical Operations Insights

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Solutions to your Problems

Industry Researched Topics

Senior Decision Makers

Meet Our Facilitators

Anthony Maida

Christie Quarles

David Crean

Elie Arslan

George Ng

Glenn Guthrie

Jacqui Blem

Janal Urich

John Mattison

Joseph Shan

Peter Stiegler

Sandy Wiley

Shaun MacEachern

Tara Lehner

Our Agenda

See Which Topics Are Up For Discussion

Breakfast & Registration

Opening Keynote Presentation

Roundtable ( Pharma/Biotech )

Roundtable Tracks

Refreshment Break

Networking/1-1 Meetings

Roundtable ( Pharma/Biotech )

Roundtable Tracks

Networking Lunch

Networking / 1-1 Meetings

Afternoon Keynote Presentation

Revvity Signals – From Oversight to Insight: Accelerating Clinical Operations with AI-Augmented Data Review

Roundtable ( Pharma/Biotech )

Roundtable Tracks

Panel Discussion

Drinks & Canapes Reception

Reasons To Attend Our Strategy Meetings

Fully Interactive Format

Senior Decision Makers

Personalised Agendas

Private and Intimate Networking

Our 2025 Sponsor

Partnering Sponsor

Key Opinion Leader

Media Partners

Explore Highlight From The Past Events

Press play to hear what your colleagues had to say…

Hotel & Venue

Hard Rock Hotel San Diego

Want to find out more?

Here To Help

Select days you wish to attend You can add multiple days

Daily Delegate Rate includes:

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Hard Rock Hotel San Diego